Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Genetic variants in a 'cAMP element binding protein' (CREB)-dependent histone acetylation pathway influence memory performance in cognitively healthy elderly individuals.

Barral S, Reitz C, Small SA, Mayeux R.

Neurobiol Aging. 2014 Dec;35(12):2881.e7-2881.e10. doi: 10.1016/j.neurobiolaging.2014.06.024. Epub 2014 Jun 28.

2.

Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span.

Li G, Millard SP, Peskind ER, Zhang J, Yu CE, Leverenz JB, Mayer C, Shofer JS, Raskind MA, Quinn JF, Galasko DR, Montine TJ.

JAMA Neurol. 2014 Jun;71(6):742-51. doi: 10.1001/jamaneurol.2014.445.

3.

Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice.

Klein RC, Acheson SK, Mace BE, Sullivan PM, Moore SD.

Neurobiol Aging. 2014 Sep;35(9):2046-52. doi: 10.1016/j.neurobiolaging.2014.02.019. Epub 2014 Mar 2.

4.

The APOE ε4 allele in relation to brain white-matter microstructure in adulthood and aging.

Nyberg L, Salami A.

Scand J Psychol. 2014 Jun;55(3):263-7. doi: 10.1111/sjop.12099. Epub 2014 Feb 8.

PMID:
24506254
5.

APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease.

Donix M, Burggren AC, Scharf M, Marschner K, Suthana NA, Siddarth P, Krupa AK, Jones M, Martin-Harris L, Ercoli LM, Miller KJ, Werner A, von Kummer R, Sauer C, Small GW, Holthoff VA, Bookheimer SY.

Psychiatry Res. 2013 Dec 30;214(3):212-20. doi: 10.1016/j.pscychresns.2013.09.006. Epub 2013 Sep 27.

6.

APOE ϵ 4, aging, and effects on white matter across the adult life span.

Felsky D, Voineskos AN.

JAMA Psychiatry. 2013 Jun;70(6):646-7. doi: 10.1001/jamapsychiatry.2013.865. No abstract available.

PMID:
23740051
7.

Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects.

Rodrigue KM, Rieck JR, Kennedy KM, Devous MD Sr, Diaz-Arrastia R, Park DC.

JAMA Neurol. 2013 May;70(5):600-6. doi: 10.1001/jamaneurol.2013.1342.

8.

Brain network local interconnectivity loss in aging APOE-4 allele carriers.

Brown JA, Terashima KH, Burggren AC, Ercoli LM, Miller KJ, Small GW, Bookheimer SY.

Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20760-5. doi: 10.1073/pnas.1109038108. Epub 2011 Nov 21.

9.

Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis.

Han SD, Bondi MW.

Alzheimers Dement. 2008 Jul;4(4):251-4. doi: 10.1016/j.jalz.2008.02.006. Epub 2008 Apr 24.

PMID:
18631975
10.

Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.

Peskind ER, Li G, Shofer J, Quinn JF, Kaye JA, Clark CM, Farlow MR, DeCarli C, Raskind MA, Schellenberg GD, Lee VM, Galasko DR.

Arch Neurol. 2006 Jul;63(7):936-9.

PMID:
16831961
11.

The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.

Kuo YM, Beach TG, Sue LI, Scott S, Layne KJ, Kokjohn TA, Kalback WM, Luehrs DC, Vishnivetskaya TA, Abramowski D, Sturchler-Pierrat C, Staufenbiel M, Weller RO, Roher AE.

Mol Med. 2001 Sep;7(9):609-18.

12.

Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans.

Moghadasian MH, McManus BM, Nguyen LB, Shefer S, Nadji M, Godin DV, Green TJ, Hill J, Yang Y, Scudamore CH, Frohlich JJ.

FASEB J. 2001 Dec;15(14):2623-30.

13.

Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype.

Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong LM, Jakes R, Alberts MJ, Gilbert JR, et al.

Exp Neurol. 1994 Feb;125(2):163-71; discussion 172-4. Review.

PMID:
8313935
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk